Formulation development
Design of pharmaceutical formulations focused on performance, stability, scalability, and regulatory compliance.
From the laboratory to commercial manufacturing.
We integrate research, development, technology transfer, and specialized manufacturing to accelerate your product's path to market.
Capabilities ecosystem
Is your product compatible with our capabilities?
Explore our development infrastructure, technology platforms, therapeutic expertise, and manufacturing capabilities to assess collaboration potential from the earliest stages through scaled production.
Research and development
Science, innovation, and scale-up connected from the start.
Our multidisciplinary teams integrate formulation, analytical development, quality, regulatory, and manufacturing to design robust, scalable products prepared for the challenges of the global market.
Dosage forms
Authorized dosage forms by production line.
These categories reflect the dosage forms authorized for each production line. Final applicability is confirmed against the current sanitary license for each facility.
Solid dosage forms
Tablets or compressed tablets, coated tablets, hard gelatin capsules, powders, and granules.
Sterile dosage forms
Injectable suspension in vial, ophthalmic solution, injectable solution in vial, powder for injectable solution in vial, among others.
Liquid dosage forms
Solution, suspension, and syrup.
Technologies
Specialized infrastructure for highly complex pharmaceutical processes.
Biotechnological manufacturing
Sterile manufacturing
Complex pharmaceutical manufacturing
Therapeutic expertise
Specialized knowledge in critical areas of healthcare.
Oncology
Anti-infectives
Dialysis
Neurology
Nutrition
Development platforms
Specialized capabilities for complex pharmaceutical challenges.
We combine scientific expertise, manufacturing knowledge, and technological infrastructure to develop products with specific formulation, stability, and performance requirements.
Lyophilization development
Development of formulations and lyophilization cycles focused on preserving product stability, quality, and shelf life.
Preservative-free ophthalmic development
Specialized capabilities for ophthalmic products requiring high standards of safety, sterility, and clinical performance.
Advanced oral solid formulation
Development of solid dosage forms with release, bioavailability, and manufacturability approaches adapted to product objectives.
Softgel formulation
Experience in lipid-based systems and softgels designed to optimize delivery and stability.